These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


325 related items for PubMed ID: 28985804

  • 21. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis.
    Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS.
    Ophthalmology; 1997 Feb; 104(2):236-44. PubMed ID: 9052627
    [Abstract] [Full Text] [Related]

  • 22. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study.
    Kotaniemi K, Kautiainen H, Karma A, Aho K.
    Ophthalmology; 2001 Nov; 108(11):2071-5. PubMed ID: 11713082
    [Abstract] [Full Text] [Related]

  • 23. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
    Calvo-Río V, Santos-Gómez M, Calvo I, González-Fernández MI, López-Montesinos B, Mesquida M, Adán A, Hernández MV, Maíz O, Atanes A, Bravo B, Modesto C, Díaz-Cordovés G, Palmou-Fontana N, Loricera J, González-Vela MC, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.
    Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756
    [Abstract] [Full Text] [Related]

  • 24. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.
    Heiligenhaus A, Klotsche J, Tappeiner C, Sengler C, Niewerth M, Liedmann I, Hoeft S, Walscheid K, Lavric M, Foell D, Minden K.
    Rheumatology (Oxford); 2019 Jun 01; 58(6):975-986. PubMed ID: 30590748
    [Abstract] [Full Text] [Related]

  • 25. Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis.
    Liang F, Terrada C, Ducos de Lahitte G, Quartier P, Lehoang P, Thorne JE, Bodaghi B.
    Ocul Immunol Inflamm; 2016 Aug 01; 24(4):386-91. PubMed ID: 26171661
    [Abstract] [Full Text] [Related]

  • 26. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis.
    Yu EN, Paredes I, Foster CS.
    Ocul Immunol Inflamm; 2007 Aug 01; 15(1):11-7. PubMed ID: 17365801
    [Abstract] [Full Text] [Related]

  • 27. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    J Rheumatol; 2016 Dec 01; 43(12):2183-2188. PubMed ID: 27633821
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ocular threat in juvenile idiopathic arthritis.
    Marvillet I, Terrada C, Quartier P, Quoc EB, Bodaghi B, Prieur AM.
    Joint Bone Spine; 2009 Jul 01; 76(4):383-8. PubMed ID: 19524473
    [Abstract] [Full Text] [Related]

  • 30. Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
    Papadopoulou M, Zetterberg M, Oskarsdottir S, Andersson Grönlund M.
    Acta Ophthalmol; 2017 Nov 01; 95(7):741-747. PubMed ID: 28205413
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Epidemiology, Treatment, and Outcomes of Juvenile Idiopathic Arthritis-Associated Uveitis: A Multi-Institutional Study in Taiwan.
    Wu PY, Kang EY, Chen WD, Chiang WY, Wu CH, Wu CY, Chen KJ, Wu WC, Chou HD, Chao AN, Hwang YS.
    Ocul Immunol Inflamm; 2023 Dec 01; 31(10):2009-2017. PubMed ID: 36696667
    [Abstract] [Full Text] [Related]

  • 35. Juvenile idiopathic arthritis-associated uveitis in the era of biological therapy: how the disease changed in more than 20 years of observation in a tertiary referral center in Rome (Italy).
    Del Giudice E, Simio C, Scala A, Di Coste A, La Torre G, Spadea L, Lubrano R, Duse M, Paroli MP.
    Int Ophthalmol; 2022 Mar 01; 42(3):775-784. PubMed ID: 34669094
    [Abstract] [Full Text] [Related]

  • 36. Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.
    Tappeiner C, Miserocchi E, Bodaghi B, Kotaniemi K, Mackensen F, Gerloni V, Quartier P, Lutz T, Heiligenhaus A.
    J Rheumatol; 2015 Apr 01; 42(4):706-11. PubMed ID: 25641892
    [Abstract] [Full Text] [Related]

  • 37. Juvenile arthritis-associated uveitis: visual outcomes and prognosis.
    Chen CS, Roberton D, Hammerton ME.
    Can J Ophthalmol; 2004 Oct 01; 39(6):614-20. PubMed ID: 15559647
    [Abstract] [Full Text] [Related]

  • 38. Juvenile idiopathic arthritis-associated uveitis.
    Clarke SL, Sen ES, Ramanan AV.
    Pediatr Rheumatol Online J; 2016 Apr 27; 14(1):27. PubMed ID: 27121190
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial.
    Horton S, Jones AP, Guly CM, Hardwick B, Beresford MW, Lee RW, Dick AD, Ramanan AV.
    Am J Ophthalmol; 2019 Nov 27; 207():170-174. PubMed ID: 31201796
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.